| JYHZ2500095 | 布地奈德福莫特罗吸入粉雾剂(II) | budesonide;formoterol fumarate | Inhalation | Chemical Drugs | License Renew | 2025-04-23 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
| CYHS2500591 | 布地奈德福莫特罗吸入粉雾剂（Ⅱ） | budesonide;formoterol fumarate | Inhalation | Chemical Drugs(4) | Generic Drug | 2025-02-07 | | Shanghai Xinyi Huanghe Pharmaceutical Co Ltd | | | view |
| JTH2400027 | 布地奈德福莫特罗吸入粉雾剂安慰剂 | budesonide;formoterol fumarate | Inhalation | Chemical Drugs | Disposable Import Drug Application | 2024-02-29 | | Hainan Merlot Kang Pharmaceutical Co Ltd;Orion Corporation | | | view |
| CYHB2302309 | 布地奈德福莫特罗吸入粉雾剂（Ⅱ） | budesonide;formoterol fumarate | Inhalation | Chemical Drugs(4) | Supplementary Application | 2023-10-18 | | Shanghai Xinyi Huanghe Pharmaceutical Co Ltd | | | view |
| JYHZ2300379 | 布地奈德福莫特罗吸入粉雾剂(I) | budesonide;formoterol fumarate | Inhalation | Chemical Drugs | License Renew | 2023-09-15 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
| JYHZ2300380 | 布地奈德福莫特罗吸入粉雾剂(II) | budesonide;formoterol fumarate | Inhalation | Chemical Drugs | License Renew | 2023-09-15 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
| JYHZ2300381 | 布地奈德福莫特罗吸入粉雾剂(II) | budesonide;formoterol fumarate | Inhalation | Chemical Drugs | License Renew | 2023-09-15 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
| CXHL2300939 | 布地奈德福莫特罗吸入粉雾剂（胶囊型） | budesonide;formoterol fumarate | Inhalation | Chemical Drugs(2.2) | New Drug Application | 2023-09-01 | | Zhuhai Resproly Pharmaceutical Technology Co Ltd | | | view |
| CYHL2200062 | 布地奈德福莫特罗吸入粉雾剂（Ⅱ） | budesonide;formoterol fumarate | Inhalation | Chemical Drugs(4) | Generic Drug | 2022-08-09 | | Shanghai Xinyi Huanghe Pharmaceutical Co Ltd | | | view |
| JYHL2100003 | 布地奈德福莫特罗吸入粉雾剂 | budesonide;formoterol fumarate | Inhalation | Chemical Drugs(5.2) | Import Drug Application | 2021-02-11 | | Orion Corporation | In Review | 2021-02-11 | view |
| JYHL2100002 | 布地奈德福莫特罗吸入粉雾剂 | budesonide;formoterol fumarate | Inhalation | Chemical Drugs(5.2) | Import Drug Application | 2021-02-11 | | Orion Corporation | In Review | 2021-02-11 | view |
| JYHL2100001 | 布地奈德福莫特罗吸入粉雾剂 | budesonide;formoterol fumarate | Inhalation | Chemical Drugs(5.2) | Import Drug Application | 2021-02-11 | | Orion Corporation | In Review | 2021-02-11 | view |
| JYHZ2000271 | 布地奈德福莫特罗吸入粉雾剂（II） | budesonide;formoterol fumarate | Inhalation | Chemical Drugs | License Renew | 2020-12-14 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;AstraZeneca AB | In Review | 2020-12-12 | view |
| JYHB2001181 | 布地奈德福莫特罗吸入粉雾剂（II） | budesonide;formoterol fumarate | Inhalation | Chemical Drugs | Supplementary Application | 2020-07-28 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;AstraZeneca AB | Filed | 2020-08-04 | view |
| JYHB2001180 | 布地奈德福莫特罗吸入粉雾剂（I） | budesonide;formoterol fumarate | Inhalation | Chemical Drugs | Supplementary Application | 2020-07-28 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;AstraZeneca AB | Filed | 2020-08-04 | view |
| JYHB2001183 | 布地奈德福莫特罗吸入粉雾剂（II） | budesonide;formoterol fumarate | Inhalation | Chemical Drugs | Supplementary Application | 2020-07-28 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;AstraZeneca AB | Filed | 2020-08-04 | view |
| JYHB2001182 | 布地奈德福莫特罗吸入粉雾剂（II） | budesonide;formoterol fumarate | Inhalation | Chemical Drugs | Supplementary Application | 2020-07-28 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;AstraZeneca AB | Filed | 2020-08-04 | view |
| JYHB2000244 | 布地奈德福莫特罗吸入粉雾剂（I） | budesonide;formoterol fumarate | Inhalation | Chemical Drugs | Supplementary Application | 2020-03-13 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;AstraZeneca AB | Filed | 2020-03-26 | view |
| JYHB2000247 | 布地奈德福莫特罗吸入粉雾剂（II） | budesonide;formoterol fumarate | Inhalation | Chemical Drugs | Supplementary Application | 2020-03-13 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;AstraZeneca AB | Filed | 2020-03-26 | view |
| JYHB2000246 | 布地奈德福莫特罗吸入粉雾剂（II） | budesonide;formoterol fumarate | Inhalation | Chemical Drugs | Supplementary Application | 2020-03-13 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;AstraZeneca AB | Filed | 2020-03-26 | view |
